- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Ketamine Adverse Reaction in South Africa
Total 130 results
-
New York Blood CenterRecruitingInfusion ReactionsUnited States
-
University of ManitobaCanadian Institutes of Health Research (CIHR); Canadian National Transplant...RecruitingKidney Transplant; Complications | Rejection of Renal TransplantAustralia, Canada
-
The George InstituteVictor Chang Cardiac Research Institute; St Vincent's Centre for Applied Medical...RecruitingHeart Failure With Preserved Ejection FractionAustralia
-
Lexicon PharmaceuticalsCompletedCarcinoid SyndromeUnited States, Australia, Belgium, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom, Canada, Israel
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Drug/Agent Toxicity by Tissue/OrganUnited States
-
BaroNova, Inc.Completed
-
Abbott Medical DevicesCompletedAdverse Effect of MRI on an Implanted Pacemaker Lead | Adverse Effect of MRI on an Implanted PacemakerUnited States, Netherlands, Australia, Belgium, Finland
-
CareDxCompletedKidney Transplant RejectionUnited States
-
Western Sydney Local Health DistrictCompletedEndoscopic Mucosal Resection | Delayed Bleeding Post EMR | Large Laterally Spreading Lesion in the ColonAustralia
-
University of South FloridaNational Cancer Institute (NCI)CompletedBreast Cancer | Cardiac ToxicityUnited States
-
Lexicon PharmaceuticalsCompletedCarcinoid SyndromeUnited States, Australia, Belgium, Canada, France, Germany, Israel, Italy, Netherlands, Spain, Sweden, United Kingdom
-
Bristol-Myers SquibbCompletedKidney Transplantation | Graft Rejection | Renal TransplantationUnited States
-
Lexicon PharmaceuticalsCompletedCarcinoid SyndromeUnited States, Australia, Belgium, Canada, France, Germany, Israel, Spain, Sweden, United Kingdom, Netherlands
-
Wellstat TherapeuticsCompletedPancreatic Cancer | Drug/Agent Toxicity by Tissue/OrganUnited States, Canada
-
PfizerCompletedRenal Transplant | Graft Rejection | Kidney Transplant | Renal Allograft RecipientsUnited States, Australia, Germany, Italy, Spain, Brazil, Argentina
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBreast Cancer | Cardiac ToxicityUnited States
-
University of South CarolinaPrisma Health-Midlands; The Gerber FoundationRecruitingPreterm Birth | Hypothermia | Blood Transfusion ComplicationUnited States
-
Abbott Medical DevicesCompletedOptim Lead Insulation Related Adverse EventsUnited States, Belgium, Germany
-
Transplant Genomics, Inc.Recruiting
-
Novartis PharmaceuticalsCompletedKidney Transplant RejectionUnited States, Hungary, Japan, United Kingdom, Belgium, Spain, Netherlands, Germany, Australia, France, Korea, Republic of, Switzerland, Norway, Italy, Latvia, Sweden, Argentina, Brazil, Canada, Czechia
-
TFF Pharmaceuticals, Inc.RecruitingLung Transplant RejectionAustralia
-
Eledon PharmaceuticalsRecruitingKidney Transplant RejectionUnited States, Spain, Australia, Germany, France, Brazil
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLung Cancer | Radiation Toxicity | Drug/Agent Toxicity by Tissue/OrganUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphoma | Cardiac ToxicityUnited States, Canada, Switzerland
-
Addex Pharma S.A.RecruitingParkinson Disease | Dyskinesias | Dyskinesia, Drug-InducedUnited States
-
Western Sydney Local Health DistrictRecruitingColorectal Neoplasm | Endoscopic Mucosal ResectionAustralia
-
CareDxActive, not recruitingKidney Transplant RejectionUnited States
-
CareDxActive, not recruiting
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedSarcoma | Cardiac ToxicityUnited States, Canada, Netherlands, Puerto Rico, Switzerland, Australia
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedLung Cancer | Radiation Toxicity | Oral Complications | Drug/Agent Toxicity by Tissue/OrganUnited States, Canada
-
Tourmaline Bio, Inc.RecruitingChronic Kidney Diseases | Chronic Renal Insufficiency | Chronic Kidney Insufficiency | C-Reactive Protein | Chronic Renal Diseases | Kidney Insufficiency, Chronic | hsCRP | High Sensitivity C-Reactive Protein | Hs-CRPUnited States
-
Occlutech International ABActive, not recruitingHeart Failure With Preserved Ejection Fraction (HFpEF) | Heart Failure With Reduced Ejection Fraction (HFrEF)United States
-
Philips HealthcareMemorial Hospital of South BendWithdrawnStress | Preterm Birth | Growth Acceleration | Chronic Lung Disease | Satisfaction | Adverse Event | Low; Birthweight, Extremely (999 Grams or Less) | Neonatal InfectionUnited States
-
Alexion PharmaceuticalsTerminatedAntibody Mediated RejectionUnited States, Germany, Italy, France, United Kingdom, Spain, Sweden, Australia, Netherlands, Norway
-
Novartis PharmaceuticalsCompletedGraft RejectionUnited Kingdom, Canada, Taiwan, United States, France, Belgium, Spain, Australia, Germany, New Zealand, Argentina, Italy, Austria, Norway, Puerto Rico
-
Novartis PharmaceuticalsCompletedLiver Transplant RejectionUnited States, Belgium, Germany, Spain, Argentina, Netherlands, Italy, Hungary, France, Czechia
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingCardiotoxicity | Recurrent Breast Carcinoma | HER2/Neu Positive | Metastatic Malignant Neoplasm in the Brain | Stage IV Breast Cancer AJCC v6 and v7United States, Korea, Republic of, Puerto Rico, Saudi Arabia
-
The University of QueenslandRecruitingKidney Transplant Infection | Kidney Transplant Failure and Rejection | BK ViremiaAustralia
-
The University of QueenslandQueensland Children's Hospital; Griffith University; Royal Brisbane and Women... and other collaboratorsRecruitingWound Infection | Catheter Infection | Catheter-Related Infections | Wound | Vascular Access Complication | Catheter Complications | Device Related Infection | Wound of Skin | Catheter Related Complication | Device Related Sepsis | Occlusive Dressings | Device Site ReactionsAustralia, France
-
Axon Therapies, Inc.RecruitingHeart Failure With Preserved Ejection FractionUnited States
-
Impulse DynamicsRecruitingHeart Failure | Heart Failure With Preserved Ejection Fraction | Diastolic Heart Failure | Heart Failure With Mid Range Ejection Fraction | Heart Failure With Moderately Reduced Ejection FractionUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedAnemia | Lung Cancer | Neutropenia | Drug/Agent Toxicity by Tissue/OrganUnited States
-
University of CincinnatiRoche Pharma AG; University of TennesseeCompletedAcute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant RecipientsUnited States, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Extragonadal Germ Cell Tumor | Childhood Germ Cell Tumor | Drug/Agent Toxicity by Tissue/OrganUnited States, Canada, Netherlands, Puerto Rico, Switzerland, Australia
-
CSL BehringICON Clinical ResearchTerminatedAntibody-mediated RejectionKorea, Republic of, United States, New Zealand, Spain, Taiwan, Netherlands, Australia, France, Canada, Belgium, Czechia, Hungary, Sweden, Austria, Germany
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedColorectal Cancer | Anal Cancer | Drug/Agent Toxicity by Tissue/Organ | Radiation EnteritisUnited States
-
United States Department of DefenseTerminatedSexually Transmitted Infection (STI) Prevention | Unintended Pregnancy Prevention | Sexual Risk Reduction | Alcohol and Other Substance Use Prevention | Intimate Partner Violence PreventionUnited States
-
AstraZenecaCompletedHeart Failure With Reduced Ejection Fraction (HFrEF)United States, Canada, Denmark, Korea, Republic of, Brazil, Slovakia, Japan, South Africa, Sweden
-
Tenax Therapeutics, Inc.Active, not recruitingHeart Failure With Normal Ejection Fraction | Hypertension Pulmonary Secondary Heart Failure | Right Sided Heart Failure With Normal Ejection FractionUnited States
-
Queensland Centre for Gynaecological CancerGlaxoSmithKline Research & Development LimitedNot yet recruitingMmr Deficiency | Endometrial Cancer Stage I | Immune-related Adverse Event | Endometrioid Endometrial AdenocarcinomaAustralia